000264816 000__ 01531cam\a2200373\a\45e0
000264816 001__ 264816
000264816 005__ 20220217103201.0
000264816 008__ 021203s2002\\\\dcu\\\\\\b\\\f000\0\eng\c
000264816 020__ $$a0160691885
000264816 035__ $$a(OCoLC)ocm51110604
000264816 035__ $$a264816
000264816 040__ $$aSEN$$cSEN$$dGPO
000264816 042__ $$apcc
000264816 043__ $$an-us---
000264816 049__ $$aISEA
000264816 074__ $$a1034-A
000264816 074__ $$a1034-B (MF)
000264816 0860_ $$aY 4.AR 5/3:S.HRG.106-1124
000264816 1101_ $$aUnited States.$$bCongress.$$bSenate.$$bCommittee on Armed Services.$$bSubcommittee on Personnel.
000264816 24514 $$aThe Department of Defense antibiological warfare agent vaccine acquisition program :$$bhearing before the Subcommittee on Personnel of the Committee on Armed Services, United States Senate, One Hundred Sixth Congress, second session, April 14, 2000.
000264816 260__ $$aWashington :$$bU.S. G.P.O. :$$bFor sale by the Supt. of Docs., U.S. G.P.O. [Congressional Sales Office],$$c2002.
000264816 300__ $$aiii, 33 p. ;$$c24 cm.
000264816 4901_ $$aS. hrg. ;$$v106-1124
000264816 500__ $$a"Printed for the use of the Committee on Armed Services."
000264816 500__ $$aDistributed to some depository libraries in microfiche.
000264816 500__ $$aShipping list no.: 2003-0046-P.
000264816 504__ $$aIncludes bibliographical references.
000264816 61010 $$aUnited States.$$bDepartment of Defense.
000264816 61020 $$aBioPort Corporation.
000264816 650_0 $$aBiological warfare.
000264816 650_0 $$aVaccines$$xResearch.
000264816 650_0 $$aVaccines industry$$zUnited States.
000264816 8101_ $$aUnited States.$$bCongress.$$bSenate.$$tS. hrg. ;$$v106-1124.
000264816 85230 $$bdfich$$hY 4.AR 5/3:$$iS.HRG.106-1124
000264816 909CO $$ooai:library.usi.edu:264816$$pGLOBAL_SET
000264816 980__ $$aBIB
000264816 980__ $$aGOV RESOURCE
000264816 994__ $$aE0$$bISE